Applying Trovera in clinical practice – putting information into action
The following case studies demonstrate how Trovera tests are being integrated into clinical practice to provide critical information about changes in driver mutations earlier in the course of treatment in advance of radiographic scans and potentially supplanting the need for repeat biopsies. The body of clinical evidence continues to grow as additional results from our clinical study programs and case studies from physicians become available.
Sumi is a 72-year old female who was diagnosed with non-small cell lung cancer. In her case, Trovera was used to detect EGFR T790M resistance mutation.
Julie is a 39-year old female who was diagnosed with a high-grade rectal neuroendocrine tumor. In her case, Trovera was used to monitor her response to an experimental therapy.
Liquid Biopsy Impacts Patient Care: Susann’s Story
See firsthand how the Trovera urine liquid biopsy test made a difference for a patient with late-stage non-small cell lung cancer, enabling her physician to make an informed treatment decision without the need for a repeat tissue biopsy.